Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01828021 |
| Title | Phase 2 Study of the Monoclonal Antibody MGAH22(Margetuximab)in Patients With Relapsed or Refractory Advanced Breast Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | MacroGenics |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94115 | United States | Details | |
| Stanford University | Stanford | California | 94305 | United States | Details | |
| Florida Cancer Research Institute | Plantation | Florida | 33324 | United States | Details | |
| Indiana University | Indianapolis | Indiana | 46202 | United States | Details | |
| Tufts Cancer Center | Boston | Massachusetts | 02111 | United States | Details | |
| Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details |